Skip to main content

CY-931

ADVERTISEMENT
Identification
Molecular formula
C26H37N3O2
CAS number
1379686-29-7
IUPAC name
N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide
State
State

At room temperature, CY-931 is in a solid state, specifically a crystalline powder, which is typical for many organic compounds used in pharmaceutical applications.

Melting point (Celsius)
202.50
Melting point (Kelvin)
475.70
Boiling point (Celsius)
598.15
Boiling point (Kelvin)
871.30
General information
Molecular weight
439.60g/mol
Molar mass
439.6020g/mol
Density
1.1895g/cm3
Appearence

CY-931 typically appears as a white to off-white crystalline solid. It is often available in powder form for use in research and pharmaceutical studies.

Comment on solubility

Solubility of N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide

This compound, with the chemical formula C26H37N3O2, exhibits interesting solubility characteristics that warrant our attention. Understanding its solubility is crucial for applications in pharmaceuticals, where bioavailability can greatly influence efficacy.

Factors Influencing Solubility

The solubility of this compound can be influenced by several factors:

  • Polarity: The presence of both the cyclohexanecarboxamide group and the aromatic systems can affect the overall polarity, leading to differentiated solubility in polar and non-polar solvents.
  • Hydrogen bonding: The amide functional group can engage in hydrogen bonding, which may enhance solubility in polar solvents, particularly in water.
  • Temperature: As is typical with many organic compounds, an increase in temperature may enhance solubility.
  • pH Levels: The solubility may also vary with pH, particularly due to the possible ionization of the nitrogen atom(s) under varying pH conditions.

Expected Solubility

Considering its structure, we can anticipate that:

  • This compound is expected to be moderately soluble in organic solvents such as ethanol and methanol.
  • It may show limited solubility in water due to the large hydrophobic cyclohexane moiety.
  • Interactions with various solvents can enhance its solubility, especially if co-solvents or surfactants are employed.

In conclusion, the solubility profile of N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide is multifaceted and primarily dictated by its molecular structure and environmental conditions. Understanding these nuances can help guide the compound's application in various fields.

Interesting facts

Exploring N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide

This compound, often abbreviated as a long and complex name, belongs to a fascinating class of chemicals known as cyclohexanecarboxamides. Its unique structure combines elements from multiple functional groups, making it a subject of interest in various fields of research.

Key Features

  • Multi-Functional Structure: The presence of both a piperazine and a pyridyl moiety in the molecule suggests potential pharmaceutical applications, particularly in the realm of psychotropic drug development.
  • Pharmacological Potential: Compounds like this one are often studied for their effects on the central nervous system. The modification of phenyl and cyclohexyl groups may lead to varying interactions with neurotransmitter receptors.
  • Versatile Synthetic Pathways: Chemists are fascinated by the synthetic methodologies employed in the production of such complex compounds, which often include various coupling reactions and the manipulation of nitrogen-containing rings.

Research and Development

This compound boasts potential not only in medicinal chemistry but also in specific applications such as:

  1. Investigating anxiolytic effects, particularly due to its piperazine component, which is known for modulating serotonin pathways.
  2. Studying its antidepressant properties as the chemical structure suggests affinity for dopamine receptors.
  3. Exploring its role as a lead compound in developing new therapeutic agents targeting anxiety and depression.

In summary, N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide is a compound that exemplifies the intricate relationship between molecular structure and biological activity. Its diverse functional groups pave the way for exciting research opportunities, making it a promising candidate in drug discovery endeavors.

Synonyms
WAY-100635
162760-96-5
Way 100635
cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-
N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide
CHEMBL31354
71IH826FEG
WAY100635
WAY-100635 maleate
N-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-N-(pyridin-2-yl)cyclohexanecarboxamide
N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide
WAY 100,635
3YQY8P5QGX
cyclohexanecarboxamide, N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-2-pyridinyl-
n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinylcyclohexanecarboxamide
634908-75-1
UNII-71IH826FEG
Rec 0/0277
[3H]WAY100635
158238-18-7
WAY-100,635
Lopac-W-108
GTPL80
Lopac0_001229
SCHEMBL84178
GTPL3251
WAY 100635 trihydrochloride
BDBM86708
DTXSID20167467
CHEBI:125619
EX-A1053
MGA76096
WFA71497
PDSP1_001716
PDSP2_001699
AKOS027313833
CCG-205303
CS-0418
NSC_104911
SB19513
SDCCGSBI-0051196.P002
NCGC00016092-01
NCGC00016092-02
NCGC00016092-03
NCGC00016092-13
NCGC00016092-14
NCGC00162372-01
AS-74088
HY-10349
CAS_146714-97-8
E77981
L000012
Q7946879
BRD-K69812556-305-02-0
N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYL-CYCLOHEXANECARBOXAMIDE TRIHYDROCHLORIDE
N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide-Tritiated